gg trend glp-1 reviews Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports Frontiers | Revisiting food addiction

This article examines how GLP-1 medications influence bowel function and provides practical guidance for managing digestive symptoms

Clues from laboratory models and clinical trials

Heres the reality check: Drinking oats this way may raise GLP-1 in the body slightly, but its not anything like these injections, Rao says

doi: 10.23876/j.krcp.22.001 56 AstrupACarraroRFinerNHarperAKunesovaMLeanMEet al

Mayo Clinics ENDO 2025 study of 120 postmenopausal women found tirzepatide plus HRT produced 17% weight loss vs 14% alone over 18 months, with 45% of HRT users hitting 20%+ loss vs 18% of non-users (see our tirzepatide vs semaglutide analysis)

Patients should be aware of warning signs and seek medical advice if severe or unusual symptoms develop during treatment